{"id":36972,"date":"2018-03-06T09:00:00","date_gmt":"2018-03-06T07:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/?post_type=press_release&#038;p=36972"},"modified":"2023-09-06T18:39:43","modified_gmt":"2023-09-06T16:39:43","slug":"ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/","title":{"rendered":"Ipsen announces 18 posters to be presented at the 15th Annual ENETS Conference"},"content":{"rendered":"<p>Paris (France), 6 March 2018 \u2013 Ipsen (Euronext: IPN; ADR: IPSEY) today announced that<br \/>\nlanreotide (Somatuline\u00ae), cabozantinib (Cabometyx\u00ae), and telotristat ethyl (Xermelo\u00ae), alongside<br \/>\nresearch on real-world NET treatment, nuclear medicine and imaging, and the patient experience<br \/>\nwill be highlighted in 18 posters at the 15th Annual ENETS (European Neuroendocrine Tumor<br \/>\nSociety) Conference, to be held from March 7th to March 9th in Barcelona, Spain. The posters will be<br \/>\npresented during two poster sessions: March 8th from 15:20 pm to 16:05 pm (CET) and March 9th<br \/>\nfrom 10:40 am to 11:30 am (CET).<\/p>\n<p>\u201c<em>Ipsen remains committed to advancing research and education in order to better understand and<\/em><br \/>\n<em>continuously improve treatment options for patients with neuroendocrine tumors (NETs). Our goal is <\/em><em>to optimize the treatment outcomes and quality of life of patients with NETs. We are pleased to<\/em><br \/>\n<em>present encouraging scientific and clinical data from our portofolio in neuroendocrine tumors and<\/em><br \/>\n<em>carcinoid syndrome<\/em> \u201d said Sotirios Stergiopoulos, MD, Senior Vice-President, Head of Global<br \/>\nMedical Affairs (GMA) and Chief Medical Officer (CMO), Ipsen.<br \/>\nThe presentations upcoming on Cabometyx\u00ae, Xermelo\u00ae, Somatuline\u00ae and 68Ga-OPS-202 are<br \/>\nbased on the results of investigational research studies.<\/p>\n<p><b>Lanreotide (Somatuline\u00ae) is featured in 4 posters:<\/b><br \/>\no Poster H19 \u2013 Category: Medical Treatment \u2013 Chemotherapy Somatostatin Analogues, Interferon<br \/>\nTitle: Disease control in progressive pancreatic and intestinal neuroendocrine tumours by<br \/>\ncombined treatment with lanreotide autogel and temozolomide: the SONNET study<br \/>\nAuthors: M. Pavel, U.-F. Pape, M. Raderer, A. Rinke, D. H\u00f6rsch, H. Lahner, T. Denecke, A. Koch,<br \/>\nN. Liyanage, A. Raspel<br \/>\no Poster J09 \u2013 Category: Medical Treatment \u2013 Others Not Specified<br \/>\nTitle: Observational study of perception of information and quality of life in patients with<br \/>\nneuroendocrine tumor starting lanreotide \u2013 Study design<br \/>\nAuthors: V. Hautefeuille, F. Bonnetain, D. Gueguen, A. Houchard, P. Hammel<br \/>\no Poster \u2013 H14 Category: Medical Treatment \u2013 Chemotherapy Somatostatin Analogues, Interferon<br \/>\nTitle: Somatostatin Analog (SSA) Usage in Neuroendocrine Tumors (NETs): A Retrospective<br \/>\nDatabase Analysis with Supplemental Chart Review<br \/>\nAuthors: A.J. Klink, B. Feinberg, H.T. Yu, D. Ray, S. Pulgar, A. Phan, A. Vinik<br \/>\no Poster \u2013 K01 \u2013 Category: Nuclear Medicine Imaging and Therapy (PRRT)<br \/>\nTitle: Influence of Lanreotide on Uptake of [68Ga]-DOTATATE in Patients with NETs<br \/>\nAuthors: E.A. Aalbersberg, B.J. de Wi \u2013 van der Veen, L.J. Saveur,G.D. Valk, M.E.T. Tesselaar,<br \/>\nM.P.M. Stokkel<br \/>\nInvestigator-lead study<\/p>\n<p><b>Cabozantinib (Cabometyx\u00ae) is featured in 1 poster:<\/b><br \/>\no Poster I05 \u2013 Category: Medical Treatment \u2013 Targeted Therapies<br \/>\nTitle: Phase II trial of cabozantinib in patients with carcinoid and pancreatic neuroendocrine<br \/>\ntumors<br \/>\nAuthors: J. A. Chan, J. E. Faris, J. E. Murphy, L. S. Blaszkowsky, N. J. McCleary, J. A.<br \/>\nMeyerhardt, T. A. Abrams, S. Zhang, A. Reardon, B. Fitzpatrick, M. H. Kulke, D. P. Ryan<br \/>\nInvestigator-lead study<\/p>\n<p><b>Telotristat (Xermelo\u00ae) is featured in 1 poster:<\/b><br \/>\no Poster J06 Category: Medical Treatment \u2013 Others, Not Specified<br \/>\nTELESTAR\/TELECAST time to sustained BM improvement \u2013 \u201c[Lexicon-lead study]\u201d \u2013 Telotristat<br \/>\nTitle: Time to Sustained Improvement in Bowel Movement Frequency with Telotristat Ethyl:<br \/>\nAnalyses of Two Phase 3 Studies in Carcinoid Syndrome<br \/>\nAuthors: J. S. Dillon, M. H. Kulke, D. H\u00f6rsch, L. B. Anthony, R. R. P. Warner, E. Bergsland,<br \/>\nS. Welin, T. M. O\u2019Dorisio, P. L. Kunz, Chad McKee, P. Lapuerta, M. Pavel<br \/>\nLexicon-lead study<\/p>\n<p><b>68Ga-OPS202 is featured in 1 poster:<\/b><br \/>\no Poster K25 \u2013 Category: Nuclear Medicine Imaging and Therapy (PRRT)<br \/>\nTitle: Study to Evaluate the Optimal Dose of 68Ga-OPS202 as a PET Imaging Agent in Patients<br \/>\nwith GEP -NET<br \/>\nAuthors: I. Virgolini, A. Brouwers, A. Haug , H. Gr\u00f8nb\u00e6k, A. Kj\u00e6r, D. Novac, A. Ang, C. Miller,<br \/>\nJ. Kaufmann, J. Czernin<\/p>\n<p><b>6 posters present Real World Data:<\/b><br \/>\no Poster D53 \u2013 Category: Epidemiology\/Natural History\/Prognosis \u2013 Registries, Nationwide and<br \/>\nRegional Surveys<br \/>\nTitle: Prevalence of Carcinoid Syndrome in the European Union: Systematic Review<br \/>\nAuthors : G. Nayroles, A. Bergamasco, J. Mouchet, Y. Moride<br \/>\no Poster J05 \u2013 Category: Medical Treatment<br \/>\nTitle: On-going Evaluation of the Use of Resources and the Costs (UR\/C) Associated with<br \/>\nControlled or Uncontrolled Carcinoid Syndrome (CS) in Patients (pts) with Neuroendocrine<br \/>\nTumours (NETs). RECOSY Study<br \/>\nAuthors : A. Custodio, A. Carmona-Bayonas, C. Villabona, M. P\u00e9rez, G. de la Cruz, P. Jim\u00e9nez-<br \/>\nFonseca<\/p>\n<p>o Poster D05 \u2013 Category: Medical Treatment \u2013 Epidemiology Natural History\/Prognosis \u2013 Registries,<br \/>\nNationwide and Regional Surveys<br \/>\nTitle: Direct cost of metastatic gastroenteropancreatic neuroendocrine tumours (GEP-NET)<br \/>\nGrade 1 or 2 (G1\/G2) in relation to time since diagnosis shows growing importance of<br \/>\nsomatostatin analogues (SSA)<br \/>\nAuthors : D. Granfeldt, \u00c5. Bj\u00f6rstad, T. Marlow, J. Dinet, P. Myrenfors, E. Les\u00e9n, I. Bj\u00f6rholt, A-K. Elf,<br \/>\nV. Johanson<br \/>\no Poster D06 \u2013 Category: Epidemiology\/Natural History\/Prognosis \u2013 Registries, Nationwide and<br \/>\nRegional Surveys<br \/>\nTitle: Long-acting Somatostatin Analogue (LA-SSA) Treatment Durations in Patients Diagnosed<br \/>\nwith Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NET) Grade 1 or 2<br \/>\n(G1\/G2) in Sweden<br \/>\nAuthors: D. Granfeldt, \u00c5. Bj\u00f6rstad, T. Marlow, J. Dinet, P.Myrenfors, E. Les\u00e9n, I. Bj\u00f6rholt, A-K.<br \/>\nElf, V. Johanson<br \/>\no Poster D77 Category: Epidemiology\/Natural History\/Prognosis \u2013 Registries, Nationwide and<br \/>\nRegional Surveys<br \/>\nTitle: Long-acting Somatostatin Analogue (LA-SSA) Treatment Patterns in Patients Diagnosed<br \/>\nwith Metastatic Gastroenteropancreatic Neuroendocrine Tumours (GEP-NET) Grade 1 or 2<br \/>\n(G1\/G2) in Sweden<br \/>\nAuthors: \u00c5. Bj\u00f6rstad, D. Granfeldt, T. Marlow, J. Dinet, P. Myrenfors, E. Les\u00e9n, I. Bj\u00f6rholt, A-K.<br \/>\nElf, V. Johanson<\/p>\n<p>o Poster H09 \u2013 Category: Medical Treatment \u2013 Chemotherapy Somatostayin Analogues, Interferon<br \/>\nTitle: Therapeutic sequences in patients with G1-G2 neuroendocrine tumors (NETs): an<br \/>\nobservational, multicentre, prospective\/retrospective study<br \/>\nAuthors: A.A. Faggiano, S.A. Di Maio, S.B Tafuto, C.C Mocerino, A.D Di Sarno, G.E Palmieri,<br \/>\nI.F Puliafito, I.G De Luca, V.H Guarnotta, S.I Leo, L.J Tozzi, A.A Colao<br \/>\nInvestigator-lead study<\/p>\n<p><b>2 posters present data on NET and carcinoid syndrome:<\/b><br \/>\no Poster J13 \u2013 Category: Medical Treatment, Others Not Specified<br \/>\nTitle: Patient and Clinician Perspectives on Symptom Priorities across the Spectrum of<br \/>\nNeuroendocrine Tumors (NETs)<br \/>\nAuthors: K.A. Kaiser, K.A. Webster, S. Shaunfield, G.J. Greene, S.E. Yount, L. Lacson, A.B.<br \/>\nBenson III, D.M. Halperin, M. Feuilly, F. Marteau, and D. Cella<br \/>\nInvestigator-lead study<\/p>\n<p>o Poster D20 \u2013 Category: Epidemiology\/Natural History\/Prognosis \u2013 Registries, Nationwide and<br \/>\nRegional Surveys<br \/>\nTitle: Carcinoid syndrome open questions \u2013 Evaluations from a real life setting<br \/>\nAuthors: R. Fijalkowski, A. Singh, R. Baum, H. Kulkarni, K. Niepsch, D. Kaemmerer, M.<br \/>\nHommann, D. Hoersch<br \/>\nInvestigator-lead study<\/p>\n<p><b>Patient experience and quality of life is featured in 2 posters:<\/b><br \/>\no Poster D59 \u2013 Category: Epidemiology\/Natural History\/Prognosis \u2013 Registries, Nationwide and<br \/>\nRegional Surveys<br \/>\nTitle: Patient survey devoted to characterizing experience and expectations of patients with<br \/>\nNeuroendocrine Tumors (NET)<br \/>\nAuthors: M. Sarabi, D. Gueguen, E. Baudin<br \/>\no Poster J08 \u2013 Category: Medical treatment, Others Not Specified<br \/>\nTitle: Clinical Utility (CU) Evaluation of the Health-Related Quality-Of-Life (HRQoL) QLQGINET21<br \/>\nQuestionnaire (QNR) in the Treatment of Patients (pts) with Gastrointestinal (GI)<br \/>\nNeuroendocrine Tumours (NETs). QUALINETS Study<br \/>\nAuthors: J. Gallego, O. Reig, J. Sastre, I. Garc\u00eda, A. Segura, J. Capdevila, A. Carmona, I.<br \/>\nSevilla, T. Alonso, G. Crespo, L. Garc\u00eda, D. Arnau, G. de la Cruz, M. Benavent<\/p>\n<p><b>Predicting response to SSAs:<\/b><br \/>\no Poster F08 \u2013 Category: Biomarkers<br \/>\nTitle: Plasma Protein hK14 Strongly Predict Pronounced Chromogranin A Response in Small<br \/>\nIntestinal Neuroendocrine Tumor Patients After Somatostatin Analog Treatment: The Nordic<br \/>\nEXPLAIN Biomarker Study<br \/>\nAuthors: M. Kjellman, U.Knigge, S.Welin, H.Gronbaek, E.This-Evensen, H.Sorbye, MT<br \/>\nJ\u00f8rgensen, V. Johansson, S. Metso, K.Becker, T. Str\u00f6m, P.Myrenfors, R. Belusa and The<br \/>\nNordic NET Biomarker Group<\/p>\n<p><img src='https:\/\/ml-eu.globenewswire.com\/media\/MGZlODIzYzMtYThjOC00ZTQ4LWI4MWUtYjJjNDA4MDNmYzhmLTEwMTA5NDM=\/tiny\/Ipsen-SA.png' \/><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[1763,149],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ipsen announces 18 posters to be presented at the 15th Annual ENETS Conference<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen announces 18 posters to be presented at the 15th Annual ENETS Conference\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-06T16:39:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/MGZlODIzYzMtYThjOC00ZTQ4LWI4MWUtYjJjNDA4MDNmYzhmLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/\"},\"author\":{\"name\":\"IPSEN\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\"},\"headline\":\"Ipsen announces 18 posters to be presented at the 15th Annual ENETS Conference\",\"datePublished\":\"2018-03-06T07:00:00+00:00\",\"dateModified\":\"2023-09-06T16:39:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/\"},\"wordCount\":1214,\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/MGZlODIzYzMtYThjOC00ZTQ4LWI4MWUtYjJjNDA4MDNmYzhmLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"articleSection\":[\"Corporate\",\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/\",\"url\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/\",\"name\":\"Ipsen announces 18 posters to be presented at the 15th Annual ENETS Conference\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/MGZlODIzYzMtYThjOC00ZTQ4LWI4MWUtYjJjNDA4MDNmYzhmLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"datePublished\":\"2018-03-06T07:00:00+00:00\",\"dateModified\":\"2023-09-06T16:39:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#primaryimage\",\"url\":\"https:\/\/ml-eu.globenewswire.com\/media\/MGZlODIzYzMtYThjOC00ZTQ4LWI4MWUtYjJjNDA4MDNmYzhmLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\",\"contentUrl\":\"https:\/\/ml-eu.globenewswire.com\/media\/MGZlODIzYzMtYThjOC00ZTQ4LWI4MWUtYjJjNDA4MDNmYzhmLTEwMTA5NDM=\/tiny\/Ipsen-SA.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ipsen announces 18 posters to be presented at the 15th Annual ENETS Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/#website\",\"url\":\"https:\/\/www.ipsen.com\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0\",\"name\":\"IPSEN\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g\",\"caption\":\"IPSEN\"},\"sameAs\":[\"https:\/\/www.ipsen.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen announces 18 posters to be presented at the 15th Annual ENETS Conference","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/","og_locale":"en_US","og_type":"article","og_title":"Ipsen announces 18 posters to be presented at the 15th Annual ENETS Conference","og_url":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/","og_site_name":"Global","article_modified_time":"2023-09-06T16:39:43+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/MGZlODIzYzMtYThjOC00ZTQ4LWI4MWUtYjJjNDA4MDNmYzhmLTEwMTA5NDM=\/tiny\/Ipsen-SA.png"}],"twitter_card":"summary_large_image","twitter_site":"@ipsengroup","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#article","isPartOf":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/"},"author":{"name":"IPSEN","@id":"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0"},"headline":"Ipsen announces 18 posters to be presented at the 15th Annual ENETS Conference","datePublished":"2018-03-06T07:00:00+00:00","dateModified":"2023-09-06T16:39:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/"},"wordCount":1214,"publisher":{"@id":"https:\/\/www.ipsen.com\/#organization"},"image":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/MGZlODIzYzMtYThjOC00ZTQ4LWI4MWUtYjJjNDA4MDNmYzhmLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","articleSection":["Corporate","Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/","url":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/","name":"Ipsen announces 18 posters to be presented at the 15th Annual ENETS Conference","isPartOf":{"@id":"https:\/\/www.ipsen.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/ml-eu.globenewswire.com\/media\/MGZlODIzYzMtYThjOC00ZTQ4LWI4MWUtYjJjNDA4MDNmYzhmLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","datePublished":"2018-03-06T07:00:00+00:00","dateModified":"2023-09-06T16:39:43+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#primaryimage","url":"https:\/\/ml-eu.globenewswire.com\/media\/MGZlODIzYzMtYThjOC00ZTQ4LWI4MWUtYjJjNDA4MDNmYzhmLTEwMTA5NDM=\/tiny\/Ipsen-SA.png","contentUrl":"https:\/\/ml-eu.globenewswire.com\/media\/MGZlODIzYzMtYThjOC00ZTQ4LWI4MWUtYjJjNDA4MDNmYzhmLTEwMTA5NDM=\/tiny\/Ipsen-SA.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/press-releases\/ipsen-announces-18-posters-to-be-presented-at-the-15th-annual-enets-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/"},{"@type":"ListItem","position":2,"name":"Ipsen announces 18 posters to be presented at the 15th Annual ENETS Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/#website","url":"https:\/\/www.ipsen.com\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]},{"@type":"Person","@id":"https:\/\/www.ipsen.com\/#\/schema\/person\/81bf851fdec8a6fd535e94f631c502b0","name":"IPSEN","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9567f50289ed3f8d4c65927e8de9f6fc?s=96&d=mm&r=g","caption":"IPSEN"},"sameAs":["https:\/\/www.ipsen.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release\/36972"}],"collection":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/users\/1"}],"version-history":[{"count":2,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release\/36972\/revisions"}],"predecessor-version":[{"id":36975,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/press_release\/36972\/revisions\/36975"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/media?parent=36972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/categories?post=36972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/tags?post=36972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}